User login
Unable to attend the Miami Breast Cancer Conference? No problem. Oncology Practice will be sending out daily e-mail updates from the conference with summaries of the presentations and video interviews with thought leaders in attendance. Conference presentations will not only cover novel treatment approaches, but also will outline the specifics for applying state-of-the-art treatment strategies to care for patients with breast cancer. Several controversies in the field also will be discussed.
Highly anticipated sessions include: a point/counterpoint on BCT vs. Mastectomy: Is It Time to Stop Giving Patients a Choice?; The Pros and Cons of Contralateral Risk-Reducing Mastectomy; An Immunotherapy Update on Vaccines; and New Developments in Adjuvant Endocrine Therapy in Premenopausal Patients.
View the complete program here and look for multimedia conference coverage to arrive in your e-mail inbox beginning March 11.
Unable to attend the Miami Breast Cancer Conference? No problem. Oncology Practice will be sending out daily e-mail updates from the conference with summaries of the presentations and video interviews with thought leaders in attendance. Conference presentations will not only cover novel treatment approaches, but also will outline the specifics for applying state-of-the-art treatment strategies to care for patients with breast cancer. Several controversies in the field also will be discussed.
Highly anticipated sessions include: a point/counterpoint on BCT vs. Mastectomy: Is It Time to Stop Giving Patients a Choice?; The Pros and Cons of Contralateral Risk-Reducing Mastectomy; An Immunotherapy Update on Vaccines; and New Developments in Adjuvant Endocrine Therapy in Premenopausal Patients.
View the complete program here and look for multimedia conference coverage to arrive in your e-mail inbox beginning March 11.
Unable to attend the Miami Breast Cancer Conference? No problem. Oncology Practice will be sending out daily e-mail updates from the conference with summaries of the presentations and video interviews with thought leaders in attendance. Conference presentations will not only cover novel treatment approaches, but also will outline the specifics for applying state-of-the-art treatment strategies to care for patients with breast cancer. Several controversies in the field also will be discussed.
Highly anticipated sessions include: a point/counterpoint on BCT vs. Mastectomy: Is It Time to Stop Giving Patients a Choice?; The Pros and Cons of Contralateral Risk-Reducing Mastectomy; An Immunotherapy Update on Vaccines; and New Developments in Adjuvant Endocrine Therapy in Premenopausal Patients.
View the complete program here and look for multimedia conference coverage to arrive in your e-mail inbox beginning March 11.